IL6 and myalgic encephalomeyelitis/chronic fatigue syndrome: After 6–8 weeks of administration, this probiotic strain reduces plasma CRP levels in all three conditions, reduces TNFα in chronic fatigue syndrome and psoriasis, and reduces IL-6 in UC and chronic fatigue syndrome.131